نتائج البحث من 61 إلى 70 من أصل 45358 لعبارة Tumor
The cause of benign adrenal tumors often is not known. عوامل الخطورة. The following might raise the risk of developing a benign adrenal tumor: A family history ...
Patients will have tumor biopsies at screening and EOT to evaluate PDL1 expression and TME. Blood samples will be taken for PK and immune response studies. STI- ...
... tumor resection. Intraoperative blood salvage is a relatively safe and cost-effective alternative to allogeneic blood transfusion during procedures with ...
... tumor surgery in order to facilitate a longitudinal access to cerebrospinal fluid ... tumor cells in patients with advanced pancreatic neuroendocrine tumors.
... Tumor Treatment Fields (TTF) in preventing tumor growth in paitents with recurrent recurrent and/or metastatic pancreatic cancer (met-PC). A Study of SGN ...
Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...
... Tumor Treatment Fields (TTF) in preventing tumor growth in paitents with recurrent recurrent and/or metastatic pancreatic cancer (met-PC). Study of AG-270 ...
... tumors considered to be topoisomerase 1 inhibitor-sensitive. The primary purpose of Part 2 (Tumor Group Expansion Cohorts) of this study is to evaluate anti- ...
... tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving nivolumab, ipilimumab, and radiation ...
Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving nivolumab, ipilimumab, and radiation therapy may kill more cancer cells.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.